BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

800 related articles for article (PubMed ID: 25654377)

  • 41. Distribution of human papillomavirus types in ThinPrep Papanicolaou tests classified according to the Bethesda 2001 terminology and correlations with patient age and biopsy outcomes.
    Evans MF; Adamson CS; Papillo JL; St John TL; Leiman G; Cooper K
    Cancer; 2006 Mar; 106(5):1054-64. PubMed ID: 16421920
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Performance of human papillomavirus typing test in cervical precancer lesions and cervical cancer screening].
    Zhang SK; Luo XP; Li ZF; Su Z; Xia JC; Hu GY; Zhu YJ; Xie LX; Feng XX; Sun XB; Chen W; Qiao YL
    Zhonghua Zhong Liu Za Zhi; 2020 Mar; 42(3):252-256. PubMed ID: 32252206
    [No Abstract]   [Full Text] [Related]  

  • 43. Performance of HPV DNA testing with hybrid capture 2 in triaging women with minor cervical cytologic abnormalities (ASC-US/LSIL) in Northern Thailand.
    Khunamornpong S; Settakorn J; Sukpan K; Srisomboon J; Suprasert P; Siriaunkgul S
    Asian Pac J Cancer Prev; 2014; 15(24):10961-6. PubMed ID: 25605209
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Human papillomavirus testing in women with mild cytologic atypia.
    Bergeron C; Jeannel D; Poveda J; Cassonnet P; Orth G
    Obstet Gynecol; 2000 Jun; 95(6 Pt 1):821-7. PubMed ID: 10831974
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Liquid-based cytology and human papillomavirus testing: a pooled analysis using the data from 13 population-based cervical cancer screening studies from China.
    Pan QJ; Hu SY; Guo HQ; Zhang WH; Zhang X; Chen W; Cao J; Jiang Y; Zhao FH; Qiao YL
    Gynecol Oncol; 2014 May; 133(2):172-9. PubMed ID: 24631450
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intracellular human papillomavirus E6, E7 mRNA quantification predicts CIN 2+ in cervical biopsies better than Papanicolaou screening for women regardless of age.
    Pierry D; Weiss G; Lack B; Chen V; Fusco J
    Arch Pathol Lab Med; 2012 Aug; 136(8):956-60. PubMed ID: 22849745
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Test positivity cutoff level of a high risk human papillomavirus test could be increased in routine cervical cancer screening.
    Kotaniemi-Talonen L; Malila N; Nieminen P; Anttila A; Tarkkanen J; Laurila P; Hakama M
    Int J Cancer; 2008 Dec; 123(12):2902-6. PubMed ID: 18792100
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Managing atypical squamous cells of undetermined significance in Papanicolaou smears.
    Morin C; Bairati I; Bouchard C; Fortier M; Roy M; Moore L; Meisels A
    J Reprod Med; 2001 Sep; 46(9):799-805. PubMed ID: 11584480
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Is the human papillomavirus test in combination with the Papanicolaou test useful for management of patients with diagnoses of atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesions?
    Lee NW; Kim D; Park JT; Kim A
    Arch Pathol Lab Med; 2001 Nov; 125(11):1453-7. PubMed ID: 11698001
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [HPV E6 and E7 mRNA combined with HPV 16 and 18 or 45 genotyping testing as a means of cervical cancer opportunistic screening].
    Wang JJ; Dong J; Deng ZX; Wang PF; Zhang XX; Du Y
    Zhonghua Fu Chan Ke Za Zhi; 2019 May; 54(5):301-306. PubMed ID: 31154710
    [No Abstract]   [Full Text] [Related]  

  • 51. Human papillomavirus testing as triage for atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesions: sensitivity, specificity, and cost-effectiveness.
    Kaufman RH; Adam E; Icenogle J; Reeves WC
    Am J Obstet Gynecol; 1997 Oct; 177(4):930-6. PubMed ID: 9369847
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Concordance of HPV, conventional smear, colposcopy, and conization results in cervical dysplasia.
    Aydogan Kirmizi D; Baser E; Demir Caltekin M; Onat T; Sahin S; Yalvac ES
    Diagn Cytopathol; 2021 Jan; 49(1):132-139. PubMed ID: 33118711
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cost and effectiveness comparison of immediate colposcopy versus human papillomavirus DNA testing in management of atypical squamous cells of undetermined significance in Turkish women.
    Kececioglu M; Seckin B; Baser E; Togrul C; Kececioglu TS; Cicek MN; Gungor T
    Asian Pac J Cancer Prev; 2013; 14(1):511-4. PubMed ID: 23534785
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immediate histopathologic follow-up of cervista and aptima high-risk HPV assays in women with LSIL cytology.
    Zhang H; Varma KR; Han M; Matsko J; Zhao C
    Cancer Cytopathol; 2018 Aug; 126(8):525-532. PubMed ID: 29797678
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Contribution of human papillomavirus testing by hybrid capture in the triage of women with repeated abnormal pap smears before colposcopy referral.
    Fait G; Kupferminc MJ; Daniel Y; Geva E; Ron IG; Lessing JB; Bar-Am A
    Gynecol Oncol; 2000 Nov; 79(2):177-80. PubMed ID: 11063640
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Postcolposcopy management strategies for women referred with low-grade squamous intraepithelial lesions or human papillomavirus DNA-positive atypical squamous cells of undetermined significance: a two-year prospective study.
    Guido R; Schiffman M; Solomon D; Burke L;
    Am J Obstet Gynecol; 2003 Jun; 188(6):1401-5. PubMed ID: 12824969
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [A study of cervical cancer screening algorithms].
    Zhao FH; Zhang WH; Pan QJ; Zhang X; Chen W; Liu B; Ma JF; Hu SY; Qiao YL
    Zhonghua Zhong Liu Za Zhi; 2010 Jun; 32(6):420-4. PubMed ID: 20819481
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Introduction of liquid-based cytology and human papillomavirus testing in cervical cancer screening in Luxembourg.
    Latsuzbaia A; Hebette G; Fischer M; Arbyn M; Weyers S; Vielh P; Schmitt F; Mossong J
    Diagn Cytopathol; 2017 May; 45(5):384-390. PubMed ID: 28247516
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cytology and human papillomavirus testing 6 to 12 months after ASCUS or LSIL cytology in organized screening to predict high-grade cervical neoplasia between screening rounds.
    Tropé A; Sjøborg KD; Nygård M; Røysland K; Campbell S; Alfsen GC; Jonassen CM
    J Clin Microbiol; 2012 Jun; 50(6):1927-35. PubMed ID: 22518869
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Qualification of ASCUS. A comparison of equivocal LSIL and equivocal HSIL cervical cytology in the ASCUS LSIL Triage Study.
    Sherman ME; Solomon D; Schiffman M;
    Am J Clin Pathol; 2001 Sep; 116(3):386-94. PubMed ID: 11554167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.